Table 4 Univariate analysis of variables correlated with overall survival

KPS: ≤70/>70

0.0 (16.2)

5.76 (3.09-10.69)

<0.01^a

Gender: male/female

11.5 (28.6)

0.92 (0.59-1.43)

0.71

Age: >50/≤50 years

12.5 (15.6)

1.13 (0.53-1.30)

0.34

ALT(IU/I): >40 /≤40

3.8 (18.6)

2.17 (1.32-3.57)

<0.01^a

Hemoglobin (g/L): <120/≥120

9.1 (14.9)

1.71 (0.87-3.36)

0.11

LDH (IU/I): ≥245/<245

9.3 (22.6)

1.67 (1.17-2.43)

<0.01^a

ALP (IU/I): ≥110/<110

6.9 (16.1)

1.45 (0.91-2.31)

0.11

Number of lesions: >3/≤3

6.0 (25.7)

1.90 (1.19-3.03)

0.01^a

Size of lesions (cm): >3/≤3

6.3 (18.9)

1.22 (0.76-1.94)

0.40

Extrahepatic metastases: yes/no

2.8 (22.4)

1.83 (1.16-2.89)

0.01^a

Radiotherapy of primary tumor: no/yes

5.7 (28.1)

2.961 (1.79-4.75)

<0.01^a

Cycles of chemotherapy: (1-5) vs. ≥6

8.6 (18.6)

2.20 (1.38-3.52)

0.01^a

Response to chemotherapy: no/yes

0.0 (19.2)

4.03 (2.30-7.06)

<0.01^a

Local therapy of lesions: no/yes

10.4 (27.8)

1.76 (1.02-3.04)

0.05^a